MIFH
TBIO

Migdal Insurance & Financial Holdings’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,852
Closed -$509K – 697
2021
Q1 		$509K Buy
30,852
+19,146
+164% +$436K 0.01% 317
2020
Q4 		$216K Buy
+11,706
New +$210K ﹤0.01% 306

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TBIO Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 30,852 shares — an estimated $509K sold.

Migdal Insurance & Financial Holdings first reported a position in TBIO in Q4 2020 and held it in 2 quarters. The position peaked at $509K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 30,852 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $509K.
  • Migdal Insurance & Financial Holdings first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Translate Bio, Inc. Common Stock position peaked at $509K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.